EIBIR Winter School on Interdisciplinary Biomedical Imaging

17-22 January 2010, Viladrau, Spain.
The main objective of the EIBIR Winter School is to support the interdisciplinary training of technical and clinical PhD students working in the broad area of biomedical imaging. In this first EIBIR Winter School on Interdisciplinary Biomedical Imaging, two key clinical disease areas will be addressed which altogether represent the two leading causes of death worldwide: cardiovascular and oncologic diseases. Each topic will be covered from the perspective of novel methods for biomedical image acquisition, analysis and interpretation as well as from the perspective of computational modeling and interventional planning, where appropriate. The themes will be explored based on the key driving clinical questions as well as from an understanding of the underlying disease mechanisms or pathophysiology.

The faculty will include lecturers with a clinical, biomedical and technical background, from both academia and industry. Reading groups, poster sessions and social activities will be offered.

Target Group
Second- and third-year students pursuing their graduate studies within PhD programs of biomedical engineering, computer science, electrical engineering, physics, medical physics, and medicine. Participants should have a basic understanding of biomedical imaging in terms of acquisition and image analysis and interpretation. Possibility to earn CME credits.

Location
Viladrau/Spain, about 70km from Barcelona, located within the Montseny Natural Park

Application
Via email to This email address is being protected from spambots. You need JavaScript enabled to view it., until October 22nd, 2009 including:

  • Curriculum Vitae including contact details of two referees and current main supervisor
  • Letter of intention
Number of participants admitted: 45 PhD students;

Notification of selected candidates: Before November 15th 2009

Participation fees
EUR 645,- (twin room)
EUR 795,- (single room)
Including attendance of the course, full board accommodation, bus from Barcelona to Viladrau and back, all social activities. Payment of registration fees before December 1st, 2009.

For further information, please visit:
http://www.eibir.org

About EIBIR
The European Institute for Biomedical Imaging Research (EIBIR) is a non-profit limited liability company that was founded in 2006 by the European Society of Radiology (ESR), dedicated to the co-ordination of research.

EIBIR has the aim of co-ordinating and supporting the development of biomedical imaging technologies and the dissemination of knowledge with the ultimate goal of improving diagnosis, treatment and prevention of disease.

The platform supports networking activities in research and is key to spreading good practice, promoting common initiatives and interoperability in the field of biomedical imaging research.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...